Try our Advanced Search for more refined results

November 25, 2009

MERCK & CO., INC. et al v. TEVA PARENTERAL MEDICINES, INC. et al

Track this case

Case Number:

2:09-cv-06026

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Stanley R. Chesler

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 02, 2011

    Merck, Teva End Cancidas Patent Fight

    Merck & Co. Inc. on Wednesday resolved a suit in New Jersey seeking to prevent Teva Pharmaceuticals USA Inc. from marketing a generic version of anti-fungal drug Cancidas.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!